A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed Condition
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The study was conducted as an open-label, balanced, randomized, two-treatment, two-period,
two-sequence, single-dose, crossover, bioequivalence study comparing Valacyclovir
hydrochloride tablets 1 gram manufactured by OHM Laboratories Inc. NJ 08901 with VALTREX®
caplets 1 gram manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 in healthy,
adult, male, human subjects under fed condition.